VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis
VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis · First orally administered therapy for the treatment of the two main types of ANCA-associated vasculitis approved in Europe· &...
Source: pharmiweb.com